Get the Stockscreener App
3.00
2.28%
-0.07
After Hours:
3.02
0.02
+0.67%
Camp 4 Therapeutics Corp stock is traded at $3.00, with a volume of 84,253.
It is down -2.28% in the last 24 hours and up +97.37% over the past month.
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
See More
Previous Close:
$3.07
Open:
$3.1
24h Volume:
84,253
Relative Volume:
0.11
Market Cap:
$60.48M
Revenue:
$264.74M
Net Income/Loss:
$-49.71M
P/E Ratio:
-0.7324
EPS:
-4.0959
Net Cash Flow:
$-43.55M
1W Performance:
+19.05%
1M Performance:
+97.37%
6M Performance:
-25.00%
1Y Performance:
+650.00%
1-Day Range:
$2.95
$3.10
1-Week Range:
$2.60
$3.18
52-Week Range:
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Name
Camp 4 Therapeutics Corp
Sector
Industry
Phone
617-651-8867
Address
ONE KENDALL SQUARE, CAMBRIDGE, CA
Compare CAMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
3.00 | 61.89M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-27-25 | Initiated | Wedbush | Outperform |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | William Blair | Outperform |
| Aug-16-22 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-22-21 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-24-21 | Reiterated | Craig Hallum | Buy |
| Jun-25-21 | Reiterated | Craig Hallum | Buy |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Apr-17-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-05-20 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Jun-28-19 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-29-19 | Downgrade | Goldman | Neutral → Sell |
| May-01-19 | Reiterated | Craig Hallum | Buy |
| Mar-25-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-25-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-18 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-14-18 | Reiterated | B. Riley FBR | Buy |
| Dec-11-18 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Dec-11-18 | Downgrade | Northland Capital | Outperform → Market Perform |
| Nov-27-18 | Initiated | Goldman | Neutral |
| Oct-15-18 | Initiated | Jefferies | Hold |
| Sep-28-18 | Reiterated | Craig Hallum | Hold |
| Apr-27-18 | Reiterated | Craig Hallum | Hold |
| Mar-08-18 | Downgrade | Craig Hallum | Buy → Hold |
| Feb-16-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
View All
Camp 4 Therapeutics Corp Stock (CAMP) Latest News
Can Camp4 Therapeutics Corporation stock reach $100 price targetDay Trade & Community Consensus Trade Alerts - newser.com
What analysts say about Camp4 Therapeutics Corporation stockReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - Early Times
Is Camp4 Therapeutics Corporation a good long term investmentInstitutional Buying Trends & Small Budget Wealth Building - Early Times
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Price action breakdown for Camp4 Therapeutics CorporationWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
What’s next for Camp4 Therapeutics Corporation stock priceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Is Camp4 Therapeutics Corporation reversing from oversold territoryJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Applying chart zones and confluence areas to Camp4 Therapeutics CorporationMarket Growth Report & Free Long-Term Investment Growth Plans - newser.com
Backtesting results for Camp4 Therapeutics Corporation trading strategiesVolume Spike & Real-Time Volume Analysis Alerts - newser.com
How institutional ownership impacts Camp4 Therapeutics Corporation stockChart Signals & Safe Entry Momentum Tips - newser.com
Building trade automation scripts for Camp4 Therapeutics CorporationOptions Play & Consistent Profit Focused Trading Strategies - newser.com
Aug Spikes: Whats the beta of LILAK stockJuly 2025 Movers & Verified Momentum Stock Ideas - khodrobank.com
Trend analysis for Camp4 Therapeutics Corporation this weekCPI Data & High Return Stock Watch Alerts - newser.com
Analyzing Camp4 Therapeutics Corporation with multi timeframe chartsWeekly Trade Recap & Breakout Confirmation Alerts - newser.com
Aug Movers: Will Camp4 Therapeutics Corporation outperform the market in YEAR2025 Trading Recap & Real-Time Stock Entry Alerts - خودرو بانک
Patterns Watch: What are Camp4 Therapeutics Corporation’s recent SEC filings showingOptions Play & High Accuracy Swing Entry Alerts - khodrobank.com
Using AI based signals to follow Camp4 Therapeutics CorporationM&A Rumor & AI Optimized Trade Strategies - newser.com
Earnings Recap: Can ProShares Trust ProShares UltraShort SmallCap600 beat the S&P 500Quarterly Market Summary & Weekly High Return Stock Forecasts - خودرو بانک
Support Test: Is Camp4 Therapeutics Corporation likely to announce a buybackJuly 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک
Can volume confirm reversal in Camp4 Therapeutics CorporationJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Fundamentals Check: Is PSQ Holdings Inc. Equity Warrant stock overvalued or fairly pricedPortfolio Value Report & Long-Term Safe Investment Ideas - خودرو بانک
Dow Update: Is Camp4 Therapeutics Corporation a speculative investment2025 Valuation Update & Daily Stock Momentum Reports - خودرو بانک
Aug Opening: Can Camp4 Therapeutics Corporation withstand a market correctionJuly 2025 Sentiment & Technical Pattern Based Buy Signals - خودرو بانک
JPMorgan downgrades CAMP4 Therapeutics stock to Neutral on long timeline By Investing.com - Investing.com South Africa
JPMorgan downgrades CAMP4 Therapeutics stock to Neutral on long timeline - Investing.com India
Trading Recap: What are Camp4 Therapeutics Corporation’s earnings expectationsMarket Movers & Verified Momentum Stock Ideas - خودرو بانک
How to use a screener to detect Camp4 Therapeutics Corporation breakoutsPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Portfolio Update: Will Camp4 Therapeutics Corporation benefit from rising consumer demand2025 Technical Patterns & Community Supported Trade Ideas - خودرو بانک
Camp4 Therapeutics (CAMP) sees $4.5 million investment from 5AM Ventures VII, L.P. By Investing.com - Investing.com
Profit Review: Can Camp4 Therapeutics Corporation deliver alphaQuarterly Market Summary & Reliable Momentum Entry Alerts - خودرو بانک
EPS Watch: What is the target price for Camp4 Therapeutics Corporation stockWeekly Trend Summary & Weekly Momentum Stock Picks - خودرو بانک
Aug Movers: What is the target price for Camp4 Therapeutics Corporation stockWeekly Stock Report & Precise Trade Entry Recommendations - خودرو بانک
CAMP4 Therapeutics stock price target lowered to $12 at Piper Sandler - Investing.com India
Hedge Fund Moves: Can Camp4 Therapeutics Corporation beat the S&P 5002025 Big Picture & Fast Entry Momentum Alerts - khodrobank.com
Will Camp4 Therapeutics Corporation benefit from macro trendsMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Camp 4 Therapeutics Corp Stock (CAMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):